The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Standard Imaging sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Standard Imaging Inc (Standard Imaging) is as a medical device company that supplies radiation calibration and quality assurance instruments. The company provides QA software, exradin detectors, phantoms, QA beams, electrometers and brachytherapy. It offers services such as warranty information, calibration services, inspection and testing, electrometer calibration and software agreements. Standard Imaging’s products and services supports for various treatment applications such as intensity modulated radiation therapy, dosimetry, brachytherapy, image guided radiation therapy and stereotactic radiosurgery. The company caters to nuclear, health care, government laboratories and atomic energy sectors. Standard Imaging is headquartered in Middleton, Wisconsin, the US.
The key metrics of Standard Imaging related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Standard Imaging is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Standard Imaging.
For a detailed understanding of the performance of Standard Imaging, buy the report here.